Отправить статью по E-mail Validation of a Quantitative Determination Method for Ormustine in a Lyophilized Dosage Form
- Авторы: Bunyatyan N.1,2, Nikolaeva L.1,3, Olefir Y.2, Sanarova E.3, Oborotova N.1,2, Prokof’ev A.1,2, Ignat’eva E.3, Yartseva I.3, Gulyakin I.3
-
Учреждения:
- I. M. Sechenov First Moscow State Medical University (Sechenov University)
- Scientific Centre for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation
- N. N. Blokhin Russian Oncological Research Center, Russian Academy of Medical Sciences
- Выпуск: Том 51, № 11 (2018)
- Страницы: 1037-1040
- Раздел: Article
- URL: https://journals.rcsi.science/0091-150X/article/view/244899
- DOI: https://doi.org/10.1007/s11094-018-1735-3
- ID: 244899
Цитировать
Открытый доступ
Доступ предоставлен
Только для подписчиков
Аннотация
Validation results for a spectrophotometric quantitative determination method for ormustine in a lyophilized dosage form are presented. The method is shown to be suitable for quantitative determination of ormustine with respect to parameters such as specificity, linearity, accuracy, repeatability, and intermediate precision.
Ключевые слова
Об авторах
N. Bunyatyan
I. M. Sechenov First Moscow State Medical University (Sechenov University); Scientific Centre for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation
Автор, ответственный за переписку.
Email: ndbun@mail.ru
Россия, Moscow, 119991; Moscow, 127051
L. Nikolaeva
I. M. Sechenov First Moscow State Medical University (Sechenov University); N. N. Blokhin Russian Oncological Research Center, Russian Academy of Medical Sciences
Email: ndbun@mail.ru
Россия, Moscow, 119991; Moscow, 115478
Yu. Olefir
Scientific Centre for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation
Email: ndbun@mail.ru
Россия, Moscow, 127051
E. Sanarova
N. N. Blokhin Russian Oncological Research Center, Russian Academy of Medical Sciences
Email: ndbun@mail.ru
Россия, Moscow, 115478
N. Oborotova
I. M. Sechenov First Moscow State Medical University (Sechenov University); Scientific Centre for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation
Email: ndbun@mail.ru
Россия, Moscow, 119991; Moscow, 127051
A. Prokof’ev
I. M. Sechenov First Moscow State Medical University (Sechenov University); Scientific Centre for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation
Email: ndbun@mail.ru
Россия, Moscow, 119991; Moscow, 127051
E. Ignat’eva
N. N. Blokhin Russian Oncological Research Center, Russian Academy of Medical Sciences
Email: ndbun@mail.ru
Россия, Moscow, 115478
I. Yartseva
N. N. Blokhin Russian Oncological Research Center, Russian Academy of Medical Sciences
Email: ndbun@mail.ru
Россия, Moscow, 115478
I. Gulyakin
N. N. Blokhin Russian Oncological Research Center, Russian Academy of Medical Sciences
Email: ndbun@mail.ru
Россия, Moscow, 115478
